Talk:DAM-57
Add topic| This is the talk page for discussing improvements to the DAM-57 article. This is not a forum for general discussion of the subject of the article. |
Article policies
|
| Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL |
Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about DAM-57.
|
| This article is rated Stub-class on Wikipedia's content assessment scale. It is of interest to the following WikiProjects: | ||||||||||||||||||||||||||||
| ||||||||||||||||||||||||||||
| On 19 October 2025, it was proposed that this article be moved from Dimethyllysergamide to DAM-57. The result of the discussion was moved. |
Requested move
[edit]- The following discussion is an archived discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review. No further edits should be made to this section.
The result of the move request was: moved per request. Uncontested for more than a week. Favonian (talk) 14:11, 6 October 2013 (UTC)
DAM-57 → Dimethyllysergamide – Dimethyllysergamide is a more appropriate name for the article, & DAM-57 could redirect to it. DAM-57 is simply an acronym for the name Dimethyllysergamide, but Dimethyllysergamide is the actual name of the compound. Likewise, the article for LSD is not titled LSD, but rather Lysergic acid diethylamide (and LSD redirects to it). Furthermore, the only reason I was unable to move the page myself is because the page Dimethyllysergamide already existed...however, I'm the one who created it (by mistake; I copy-&-paste moved it, & then was informed by another user about the proper way to move a page, via the 'move' function, whilst preserving page history). Otherwise, I'd just move it myself. Psychonaut25 - 13375p34k / C0n7r1b5 18:43, 27 September 2013 (UTC)
- The above discussion is preserved as an archive of a requested move. Please do not modify it. Subsequent comments should be made in a new section on this talk page or in a move review. No further edits should be made to this section.
Requested move 19 October 2025
[edit]- The following is a closed discussion of a requested move. Please do not modify it. Subsequent comments should be made in a new section on the talk page. Editors desiring to contest the closing decision should consider a move review after discussing it on the closer's talk page. No further edits should be made to this discussion.
The result of the move request was: moved. (closed by non-admin page mover) Jeffrey34555 (talk) 21:14, 26 October 2025 (UTC)
Dimethyllysergamide → DAM-57 – "DAM-57" is the Sandoz developmental code name of the drug and is much more commonly used in the literature than the chemical name "dimethyllysergamide" (which is one of multiple different possible chemical names, others being "N,N-dimethyllysergamide" and "lysergic acid dimethylamide"). Per Google Scholar search results, "DAM-57" (with some disambig terms) gets 39 results (), while "dimethyllysergamide" gets 8 results (). In relation to the preceding, "DAM-57" is the common/trivial name of the compound. Moreover, typically on Wikipedia in drug-related articles, we use the developmental code names rather than chemical names as the titles of articles for investigational drugs. Finally, many other analogues or related drugs in the same series use the Sandoz developmental code name for the article title rather than a chemical name, including LAE-32, ALA-10, MLA-74, LME-54, ALD-52, LBB-66, LPD-824, MPD-75, and LSM-775. The articles in this area should follow the same naming scheme for consistency. Some exceptions include LSD (LSD-25) and ergine (LA-111), which are reasonable cases due to these compounds having other far-better-known names. Thank you. – AlyInWikiWonderland (talk, contribs) 23:57, 19 October 2025 (UTC)
- Support per nom. The prior move over 10 years ago was an uncontested request with minimal participation which can be overturned even if few editors participate here. The prior RM did not cite use in sources or any other P&G and since that time LSD and many other drug articles are now at the abbreviated, more common title. —Myceteae🍄🟫(talk) 15:13, 21 October 2025 (UTC)